162 related articles for article (PubMed ID: 38674199)
1.
Stojkovic Lalosevic M; Coric V; Pekmezovic T; Simic T; Pavlovic Markovic A; Pljesa Ercegovac M
Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674199
[No Abstract] [Full Text] [Related]
2. Genetic polymorphisms in GST genes and survival of colorectal cancer patients treated with chemotherapy.
Funke S; Timofeeva M; Risch A; Hoffmeister M; Stegmaier C; Seiler CM; Brenner H; Chang-Claude J
Pharmacogenomics; 2010 Jan; 11(1):33-41. PubMed ID: 20017670
[TBL] [Abstract][Full Text] [Related]
3. Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer.
Stoehlmacher J; Park DJ; Zhang W; Groshen S; Tsao-Wei DD; Yu MC; Lenz HJ
J Natl Cancer Inst; 2002 Jun; 94(12):936-42. PubMed ID: 12072547
[TBL] [Abstract][Full Text] [Related]
4. Deletion and Single Nucleotide Polymorphisms in Common Glutathione-S Transferases Contribute to Colorectal Cancer Development.
Stojkovic Lalosevic ML; Coric VM; Pekmezovic TD; Simic TP; Pljesa Ercegovac MS; Pavlovic Markovic AR; Krivokapic ZV
Pathol Oncol Res; 2019 Oct; 25(4):1579-1587. PubMed ID: 30694518
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants in the glutathione S-transferase genes and survival in colorectal cancer patients after chemotherapy and differences according to treatment with oxaliplatin.
Kap EJ; Richter S; Rudolph A; Jansen L; Ulrich A; Hoffmeister M; Ulrich CM; Brenner H; Chang-Claude J
Pharmacogenet Genomics; 2014 Jul; 24(7):340-7. PubMed ID: 24842074
[TBL] [Abstract][Full Text] [Related]
6. A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer.
Stoehlmacher J; Park DJ; Zhang W; Yang D; Groshen S; Zahedy S; Lenz HJ
Br J Cancer; 2004 Jul; 91(2):344-54. PubMed ID: 15213713
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of glutathione S-transferase genotyping in patients with diffuse large B-cell lymphoma.
Atanaskovic L; Cikota-Aleksic B; Tarabar O; Trimcev J; Zivanovic-Ivic A; Marjanovic S; Magic Z
J BUON; 2016; 21(6):1459-1465. PubMed ID: 28039708
[TBL] [Abstract][Full Text] [Related]
8. Glutathione S-transferase polymorphisms and survival in African-American and white colorectal cancer patients.
Jones BA; Christensen AR; Wise JP; Yu H
Cancer Epidemiol; 2009 Oct; 33(3-4):249-56. PubMed ID: 19748847
[TBL] [Abstract][Full Text] [Related]
9. Glutathione S-Transferase Gene Polymorphisms and Treatment Outcome in Cervical Cancer Patients under Concomitant Chemoradiation.
Abbas M; Kushwaha VS; Srivastava K; Banerjee M
PLoS One; 2015; 10(11):e0142501. PubMed ID: 26571237
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of GSTP1 related to response to 5-FU-oxaliplatin-based chemotherapy and clinical outcome in advanced colorectal cancer patients.
Jun L; Haiping Z; Beibei Y
Swiss Med Wkly; 2009 Dec; 139(49-50):724-8. PubMed ID: 20047135
[TBL] [Abstract][Full Text] [Related]
11. Influence of glutathione S-transferases (GSTM1, GSTT1, and GSTP1) genetic polymorphisms and smoking on susceptibility risk of chronic myeloid leukemia and treatment response.
Rostami G; Assad D; Ghadyani F; Hamid M; Karami A; Jalaeikhoo H; Kalahroodi RA
Mol Genet Genomic Med; 2019 Jul; 7(7):e00717. PubMed ID: 31111691
[TBL] [Abstract][Full Text] [Related]
12. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
[TBL] [Abstract][Full Text] [Related]
13. Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and FOLFOX response in colorectal cancer patients.
Etienne-Grimaldi MC; Milano G; Maindrault-Goebel F; Chibaudel B; Formento JL; Francoual M; Lledo G; André T; Mabro M; Mineur L; Flesch M; Carola E; de Gramont A
Br J Clin Pharmacol; 2010 Jan; 69(1):58-66. PubMed ID: 20078613
[TBL] [Abstract][Full Text] [Related]
14. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
[TBL] [Abstract][Full Text] [Related]
15. Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans.
Martínez C; Martín F; Fernández JM; García-Martín E; Sastre J; Díaz-Rubio M; Agúndez JA; Ladero JM
Pharmacogenomics; 2006 Jul; 7(5):711-8. PubMed ID: 16886896
[TBL] [Abstract][Full Text] [Related]
16. Molecular evaluation of glutathione S transferase family genes in patients with sporadic colorectal cancer.
Rodrigues-Fleming GH; Fernandes GMM; Russo A; Biselli-Chicote PM; Netinho JG; Pavarino ÉC; Goloni-Bertollo EM
World J Gastroenterol; 2018 Oct; 24(39):4462-4471. PubMed ID: 30356976
[TBL] [Abstract][Full Text] [Related]
17. Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients.
Sweeney C; Nazar-Stewart V; Stapleton PL; Eaton DL; Vaughan TL
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):527-33. PubMed ID: 12814998
[TBL] [Abstract][Full Text] [Related]
18. Glutathione-S-transferase pi (GSTP1) codon 105 polymorphism is not associated with oxaliplatin efficacy or toxicity in advanced colorectal cancer patients.
Kweekel DM; Gelderblom H; Antonini NF; Van der Straaten T; Nortier JW; Punt CJ; Guchelaar HJ
Eur J Cancer; 2009 Mar; 45(4):572-8. PubMed ID: 19084393
[TBL] [Abstract][Full Text] [Related]
19. The prognostic impact of GSTM1/GSTP1 genetic variants in bladder Cancer.
Albarakati N; Khayyat D; Dallol A; Al-Maghrabi J; Nedjadi T
BMC Cancer; 2019 Oct; 19(1):991. PubMed ID: 31646988
[TBL] [Abstract][Full Text] [Related]
20. Glutathione S-transferase P1 polymorphism (Ile105Val) predicts cumulative neuropathy in patients receiving oxaliplatin-based chemotherapy.
Lecomte T; Landi B; Beaune P; Laurent-Puig P; Loriot MA
Clin Cancer Res; 2006 May; 12(10):3050-6. PubMed ID: 16707601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
